文献速递烧伤创面修复

烧伤特异性静脉血栓栓塞预防:一项为期2年的质量改进项目

Burn-Specific Venous Thromboembolism Prophylaxis: A 2-Year Quality Improvement Project.
PubMed 文献 · J Burn Care Res · 2026-01-01

本研究评估烧伤患者静脉血栓栓塞预防新指南的依从性与结局,比较指南后(2022-2023年)与指南前(2019-2021年)队列。138例积极治疗患者中,指南前57例、指南后45例,指南后血栓栓塞事件减少但出血并发症初期增加,经术中调整后消除。

要点

  • 烧伤面积≥20%成人新指南:依诺肝素40mg每日两次,按肾功能和体重调整。
  • 指南后血栓栓塞事件减少(3例 vs 5例),但主要出血事件初期增加(15% vs 2%)。
  • 加用氨甲环酸和增加输血后,后续期间主要出血事件消除。

核心结论

  • 新指南成功实施,似可降低静脉血栓栓塞风险且并发症可接受。

研究设计与样本

  • 质量改进研究,比较指南后(2022年1月至2023年12月)与指南前(2019年7月至2021年6月)队列。
  • 共138例积极治疗患者,77%男性,中位年龄43岁,中位烧伤面积35%总体表面积。

主要发现

  • 指南前5例发生静脉血栓栓塞并发症(2例肺栓塞,3例深静脉血栓),指南后3例偶然性血栓栓塞(1例肺栓塞,2例深静脉血栓)。
  • 因出血输血两组相似,但影响真皮替代物应用的主要出血从指南前1例(2%)增至指南后7例(15%),差异无统计学意义。
  • 88%患者接受了符合指南的静脉血栓栓塞预防。

关键数值与推荐

  • 指南推荐:烧伤面积≥20%总体表面积成人,依诺肝素40mg每日两次,按肾功能和体重调整。
  • 指南前方案:依诺肝素40mg每日一次。

临床怎么用

  • 实施新指南时需监测出血并发症,尤其影响真皮替代物应用的主要出血。
  • 可考虑术中加用静脉氨甲环酸和增加输血以控制出血。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients with major burn injuries are at high risk of venous thromboembolism. In 2022, a new prophylaxis guideline was introduced for adults with burns ≥ 20% total body surface area: enoxaparin 40 mg twice daily, renally, and weight adjusted. This quality improvement study assessed compliance and outcomes by comparing patients admitted postguideline (January 2022-December 2023) to a preguideline cohort (July 2019-June 2021) who received enoxaparin 40 mg daily. Among 138 actively treated patients (77% male, median age 43 years, and median % total body surface area 35), 57 were treated preguideline and 45 post, with no major differences between groups. Preguideline, 5 patients developed venous thromboembolic complications (2 pulmonary emboli, 3 deep vein thromboses) versus 3 incidental thromboembolisms (1 pulmonary embolus, 2 deep vein thromboses) postguideline. Transfusion for bleeding was similar across groups, but major bleeding affecting dermal substitute application increased from 1 case (2%) preguideline to 7 cases (15%) postguideline, this difference was not statistically significant. To mitigate this, intravenous tranexamic acid and increased transfusion rates were implemented after 12 months, eliminating major bleeding events in the subsequent period. Overall, 88% of patients received venous thromboembolic prophylaxis in line with the guideline. Despite an initial increase in bleeding complications, intraoperative adjustments resolved these issues, demonstrating a learning curve. The guideline was successfully implemented and appears effective in reducing venous thromboembolic risk with acceptable complications.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Sheahan G, Singer Y, Xu S, et al. Burn-Specific Venous Thromboembolism Prophylaxis: A 2-Year Quality Improvement Project. J Burn Care Res. 2026. PMID: 41074776. doi:10.1093/jbcr/iraf198

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。